Gubra A/S
CSE:GUBRA
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Realty Income Corp
NYSE:O
|
Real Estate
|
| US |
|
Walt Disney Co
NYSE:DIS
|
Media
|
| US |
|
Zynex Inc
NASDAQ:ZYXI
|
Health Care
|
| US |
|
PepsiCo Inc
NASDAQ:PEP
|
Beverages
|
| IL |
|
Inmode Ltd
NASDAQ:INMD
|
Health Care
|
| UK |
|
Macfarlane Group PLC
LSE:MACF
|
Trading Companies & Distributors
|
| UK |
|
4imprint Group PLC
LSE:FOUR
|
Media
|
| UK |
|
Moneysupermarket.Com Group PLC
LSE:MONY
|
Media
|
| UK |
|
IG Group Holdings PLC
LSE:IGG
|
Financial Services
|
| UK |
|
Gaming Realms PLC
LSE:GMR
|
Media
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
114
726
|
| Price Target |
|
We'll email you a reminder when the closing price reaches DKK.
Choose the stock you wish to monitor with a price alert.
|
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
|
Nike Inc
NYSE:NKE
|
US |
|
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
|
Realty Income Corp
NYSE:O
|
US |
|
|
Walt Disney Co
NYSE:DIS
|
US |
|
|
Zynex Inc
NASDAQ:ZYXI
|
US |
|
|
PepsiCo Inc
NASDAQ:PEP
|
US |
|
|
Inmode Ltd
NASDAQ:INMD
|
IL |
|
|
Macfarlane Group PLC
LSE:MACF
|
UK |
|
|
4imprint Group PLC
LSE:FOUR
|
UK |
|
|
Moneysupermarket.Com Group PLC
LSE:MONY
|
UK |
|
|
IG Group Holdings PLC
LSE:IGG
|
UK |
|
|
Gaming Realms PLC
LSE:GMR
|
UK |
This alert will be permanently deleted.
Gubra A/S
PP&E Gross
Gubra A/S
PP&E Gross Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | PP&E Gross | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
G
|
Gubra A/S
CSE:GUBRA
|
PP&E Gross
kr63.5m
|
CAGR 3-Years
-6%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Chemometec A/S
CSE:CHEMM
|
PP&E Gross
kr92m
|
CAGR 3-Years
29%
|
CAGR 5-Years
19%
|
CAGR 10-Years
N/A
|
|
Gubra A/S
Glance View
Gubra ApS operates as biotechnology company. The Company’s operations are anchored around its advanced technology platforms and utilization of automation, robotization and digitalization, including machine learning (ML) and artificial intelligence (AI). The firm's business activity are divided into two segments: The CRO Segment offers specialized profitable pre-clinical contract research services at attractive margins within metabolic and fibrotic disease areas such as diabetes, obesity, chronic kidney disease; and The Discovery and Partnership Segment is based on an internal target and drug discovery engine for identification and design of peptide-based drug partnering candidates within metabolic and fibrotic diseases.
See Also
What is Gubra A/S's PP&E Gross?
PP&E Gross
63.5m
DKK
Based on the financial report for Dec 31, 2023, Gubra A/S's PP&E Gross amounts to 63.5m DKK.
What is Gubra A/S's PP&E Gross growth rate?
PP&E Gross CAGR 3Y
-6%
Over the last year, the PP&E Gross growth was 14%. The average annual PP&E Gross growth rates for Gubra A/S have been -6% over the past three years .
You don't have any saved screeners yet
